Clinical Trial Update: Rituximab and ABVD for Hodgkin's Patients [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating Rituximab in combination with ABVD chemotherapy for Hodgkin lymphoma; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Bleomycin (bleomycin)
• Dacarbazine (dacarbazine)
• Doxorubicin (Adriamycin) (doxorubicin)
• Rituximab (rituximab)
• Vinblastine (vinblastine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2013-07-09